Sponsor hub

Montefiore Medical Center clinical trial failures

Review 51 stopped clinical trials from Montefiore Medical Center, including disease areas, phases, and classified stop reasons.

This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 2 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.

Total stopped trials51
Likely biological signals2
Shown below51

Dominant stop reasons

OPERATIONAL
27
OTHER/UNKNOWN
22
EFFICACY/FUTILITY
2

Notable sponsors

Montefiore Medical Center
51

Related phases

Phase IV
20
Phase II
13
Phase I
5
Phase III
5
Early Phase I
4

Crawlable stopped-trial records

Open Explore

Showing up to 51 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.

NCT02953093: Study of Acarbose in Longevity

Phase II Aging trial by Montefiore Medical Center. Stop reason: OPERATIONAL.

Upon review it was determined that the study terminated early due to lack of funding. Study never reached enrollment target and was administratively closed out by the Albert Einstein College of Medicine IRB.

NCT05016622: Booster Dose Trial

Phase II Cancer trial by Montefiore Medical Center. Stop reason: OPERATIONAL.

Due to decreased level of engagement and available funding, PI determined it appropriate to close the study prior to visit occurring. IRB approved.

NCT04420585: Desmopressin for Bedwetting in Children With SCD

Phase IV Nocturnal Enuresis trial by Montefiore Medical Center. Stop reason: OPERATIONAL.

Study was not able to meet recruitment after 9 years of trying to enroll patients on different versions of the protocol and changing recruitment strategies.

NCT02620904: Mifepristone Induction for Fetal Demise

Phase IV Intrauterine Fetal Demise trial by Montefiore Medical Center. Stop reason: OPERATIONAL.

unable to recruit. Projected completion was 2018 however, enrollment and recruitment were difficult. The study was terminated due to inability to enroll.